A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma (Q69490721)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

title

A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

J C Arseneau

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

D A Schoenfeld

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

E C Borden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

2 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

53-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3700041%20AND%20SRC:MED&resulttype=core&format=json

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice

2 October 2019

cites work

1 reference

12 December 2020

Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study

1 reference

12 December 2020

Activity of mitoxantrone in a human tumor cloning system

1 reference

12 December 2020

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

1 reference

12 December 2020